The Pro Medicus Ltd (ASX: PME) share price hit $15.74 this afternoon and is now up more than 1,800% over just the past 5 years from 80 cents to today's record high.
For the six-month period ending December 31 2018 it posted a net profit after tax of $9.1 million on revenue of $25.3 million, which represented growth of 184% and 59% respectively.
The company now has a market value around $1.6 billion which investors can see is high relative to its trailing financials, however, as a software-as-a-service business it has a lot of contracted forward revenue at high profit margins which partly explains the high valuation.
It's also a market leader in a lucrative space that seemingly has a large growth runway ahead of it with management consistently delivering on claims that its sales pipeline is full.
It looks a junior healthcare stock to watch alongside the likes of Nanosonics Ltd (ASX: NAN).
